Preparation, Characterization, and Immunological Properties in Mice of Escherichia Coli O157 O-specific Polysaccharide-protein Conjugate Vaccines

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1994 Nov 1

PMID 7927787

Citations 22

Authors

E Konadu

J B Robbins

J Shiloach

D A Bryla

S C Szu

Affiliations

Soon will be listed here.

Abstract

Escherichia coli O157 causes severe enteritis and the extraintestinal complication of hemolytic-uremic syndrome, with their highest incidence occurring in children. We postulated that serum immunoglobulin G (IgG) antibodies to the O-specific polysaccharide of lipopolysaccharide (LPS) may confer protective immunity to enteric pathogens by inducing bactericidal reactions against the ingested organisms in the jejunum (J. B. Robbins, C. Chu, and R. Schneerson, Clin. Infect. Dis. 15:346-361, 1992; S. C. Szu, R. Gupta, and J. B. Robbins, p. 381-394, in I. K. Wachsmuth, P. A. Blake, and O. Olsvik, ed., Vibrio cholerae, 1994). Because polysaccharide-protein conjugates induce serum IgG antibodies in infants, we bound the O-specific polysaccharide of E. coli O157 to proteins. E. coli O157 LPS, treated with acetic acid or hydrazine, was derivatized with adipic acid dihydrazide and bound to proteins by carbodiimide-mediated condensation. Conjugates of these adipic hydrazide derivative were prepared with bovine serum albumin, formalin-treated exotoxin C of Clostridium welchii (Pig Bel toxoid), or Pseudomonas aeruginosa recombinant exoprotein A. The conjugates had low levels of endotoxin and elicited serum antibodies with bactericidal activity to the O157 LPS. The largest increase in LPS antibodies was of the IgG class. Clinical evaluation of E. coli O157-toxoid conjugates is planned.

Citing Articles

A Bivalent MAPS Vaccine Induces Protective Antibody Responses against Typhi and Paratyphi A.

Zhang F, Boerth E, Gong J, Ma N, Lucas K, Ledue O Vaccines (Basel). 2023; 11(1).

PMID: 36679935 PMC: 9865949. DOI: 10.3390/vaccines11010091.

Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of O157:H7 and O104:H4.

Dyatlov I, Svetoch E, Mironenko A, Eruslanov B, Firstova V, Fursova N Vaccines (Basel). 2022; 10(11).

PMID: 36366362 PMC: 9692684. DOI: 10.3390/vaccines10111854.

Oral Administration with Live Attenuated Citrobacter rodentium Protects Immunocompromised Mice from Lethal Infection.

Wang S, Xia X, Liu Y, Wan F Infect Immun. 2022; 90(7):e0019822.

PMID: 35861565 PMC: 9302154. DOI: 10.1128/iai.00198-22.

Intestinal Pathogenic : Insights for Vaccine Development.

Rojas-Lopez M, Monterio R, Pizza M, Desvaux M, Rosini R Front Microbiol. 2018; 9:440.

PMID: 29615989 PMC: 5869917. DOI: 10.3389/fmicb.2018.00440.

Purification and antigenic detection of O-specific polysaccharides of serovar Paratyphi A isolate from Pakistan: an emerging threat.

Rahmat Z, Ali A, Sarwar Y, Salman M, Haque A Springerplus. 2016; 5(1):1954.

PMID: 27933236 PMC: 5104697. DOI: 10.1186/s40064-016-3643-x.

References

McGowan K, Wickersham E, Strockbine N . Escherichia coli O157:H7 from water. Lancet. 1989; 1(8644):967-8. DOI: 10.1016/s0140-6736(89)92559-2. View

PAI C, Ahmed N, Lior H, Johnson W, Sims H, Woods D . Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis. 1988; 157(5):1054-7. DOI: 10.1093/infdis/157.5.1054. View

DuPont H, Levine M, Hornick R, Formal S . Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis. 1989; 159(6):1126-8. DOI: 10.1093/infdis/159.6.1126. View

Lopez E, Diaz M, Grinstein S, Devoto S, MENDILAHARZU F, Murray B . Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis. 1989; 160(3):469-75. DOI: 10.1093/infdis/160.3.469. View

Ostroff S, Tarr P, Neill M, Lewis J, Kobayashi J . Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis. 1989; 160(6):994-8. DOI: 10.1093/infdis/160.6.994. View

Robbins J, Schneerson R . Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis. 1990; 161(5):821-32. DOI: 10.1093/infdis/161.5.821. View

Ostroff S, Griffin P, Tauxe R, Shipman L, Greene K, Wells J . A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol. 1990; 132(2):239-47. DOI: 10.1093/oxfordjournals.aje.a115653. View

Lawrence G, Lehmann D, Anian G, Coakley C, Saleu G, Barker M . Impact of active immunisation against enteritis necroticans in Papua New Guinea. Lancet. 1990; 336(8724):1165-7. DOI: 10.1016/0140-6736(90)92776-e. View

Chart H, Smith H, Scotland S, Rowe B, Milford D, Taylor C . Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet. 1991; 337(8734):138-40. DOI: 10.1016/0140-6736(91)90801-u. View

10.

Chart H, Rowe B, vd Kar N, Monnens L . Serological identification of Escherichia coli O157 as cause of haemolytic uraemic syndrome in Netherlands. Lancet. 1991; 337(8738):437. DOI: 10.1016/0140-6736(91)91222-g. View

11.

Cohen D, Green M, Block C, Rouach T, Ofek I . Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J Infect Dis. 1988; 157(5):1068-71. DOI: 10.1093/infdis/157.5.1068. View

12.

MacDonald K, OLeary M, Cohen M, Norris P, Wells J, Noll E . Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA. 1988; 259(24):3567-70. View

13.

Seriwatana J, Brown J, Echeverria P, Taylor D, Suthienkul O, Newland J . DNA probes to identify Shiga-like toxin I- and II-producing enteric bacterial pathogens isolated from patients with diarrhea in Thailand. J Clin Microbiol. 1988; 26(8):1614-5. PMC: 266676. DOI: 10.1128/jcm.26.8.1614-1615.1988. View

14.

Neill R, Gemski P, Formal S, Newland J . Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence. J Infect Dis. 1988; 158(4):737-41. DOI: 10.1093/infdis/158.4.737. View

15.

Griffin P, Ostroff S, Tauxe R, Greene K, Wells J, Lewis J . Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med. 1988; 109(9):705-12. DOI: 10.7326/0003-4819-109-9-705. View

16.

Chart H, Scotland S, Rowe B . Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol. 1989; 27(2):285-90. PMC: 267293. DOI: 10.1128/jcm.27.2.285-290.1989. View

17.

Belongia E, MacDonald K, Parham G, White K, Korlath J, Lobato M . An outbreak of Escherichia coli O157:H7 colitis associated with consumption of precooked meat patties. J Infect Dis. 1991; 164(2):338-43. DOI: 10.1093/infdis/164.2.338. View

18.

Bitzan M, Moebius E, Ludwig K, Muller-Wiefel D, Heesemann J, Karch H . High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr. 1991; 119(3):380-5. DOI: 10.1016/s0022-3476(05)82049-9. View

19.

Ferreccio C, Prado V, Ojeda A, Cayyazo M, Abrego P, Guers L . Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. Am J Epidemiol. 1991; 134(6):614-27. DOI: 10.1093/oxfordjournals.aje.a116134. View

20.

Griffin P, Tauxe R . The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991; 13:60-98. DOI: 10.1093/oxfordjournals.epirev.a036079. View